ArticleScientific reports2026
Asthma prevalence and risk factors in early-onset atopic dermatitis using Korean National Health Insurance Service data.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early-onset atopic dermatitis (AD) is a common pediatric allergic disease and a potential precursor of asthma. However, population-based evidence on long-term asthma risk following early AD is scarce. This study assessed age-specific asthma prevalence and risk factors in children diagnosed with AD before age 2 using Korean National Health Insurance Service data. In this retrospective cohort, children with AD diagnoses (ICD-10: L20) at least twice before age 2 between 2008 and 2017 were included. Asthma was defined by diagnosis (ICD-10: J45, J46) and concurrent prescription of asthma medication. Patients were followed until December 2022. Standardized prevalence ratios (SPRs) were calculated relative to the general population, and multivariate logistic regression identified risk factors. Of 1,647,199 children with early-onset AD, 1,161,172 were analyzed. Asthma prevalence peaked at age 3 (29.0%) and declined to 0.5% by age 15, remaining significantly higher than in the general population. Increased risk factors included male sex, preterm birth, diagnosis before 2010, persistent AD, food allergy, and early rhinovirus or RSV infection. Diagnosis after age 1 and higher socioeconomic status were linked to lower risk. Early-onset AD is strongly associated with later asthma, highlighting the need for early identification and targeted prevention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.